[Prevention after acute coronary syndrome]

Area of Science:

• Cardiology
• Cardiac Rehabilitation
• Medical Imaging

Background:

• Acute coronary syndrome (ACS) poses significant mortality risks, influenced by myocardial injury severity.
• Percutaneous coronary intervention (PCI) is a primary treatment for ACS, but outcomes depend on residual myocardial damage.
• Congestive heart failure (CHF) development post-PCI is a critical prognostic indicator in ACS patients.

Observation:

• Non-invasive imaging is crucial for assessing structural myocardial damage and functional loss after ACS.
• The extent of myocardial injury directly correlates with increased mortality, irrespective of successful PCI.
• The presence or absence of CHF significantly influences therapeutic decisions in secondary prevention.

Findings:

• Myocardial damage extent is a key determinant of mortality in ACS patients post-PCI.
• CHF development post-PCI is a significant predictor of long-term outcomes.
• Non-invasive imaging provides essential data for evaluating myocardial status and guiding treatment.

Implications:

• Accurate assessment of myocardial injury and function is vital for tailoring secondary prevention strategies.
• Pharmacological and non-pharmacological therapies, including exercise training, should be individualized based on myocardial function and CHF status.
• Effective cardiac rehabilitation programs incorporating exercise are essential for improving outcomes in ACS survivors, considering injury severity.